Ascentage Pharma Group International (AAPG) Treasury Shares (2023 - 2025)
Ascentage Pharma Group International posted quarterly Treasury Shares of $417479.1 for Q4 2025, up 37384.91% year-on-year from N/an in Q4 2024, and up 37384.91% on a QoQ basis from $1113.7 in Q4 2024.
Ascentage Pharma Group International (AAPG) has 3 years of Treasury Shares data on file, last reported at $417479.1 in Q4 2025.
- For the quarter ending Q4 2025, Treasury Shares rose 37384.91% year-over-year to $417479.1; the trailing twelve-month figure through Dec 2025 stood at $417479.1 (up 37384.91% YoY), and the FY2025 full-year result was $423000.0, up 42200.0% from the prior year.
- Treasury Shares for Q4 2025 stood at $417479.1, up from $1113.7 in the prior quarter.
- Across five years, Treasury Shares topped out at $3.0 million in Q4 2023 and bottomed at $1113.7 in Q4 2024.
- The 3-year median for Treasury Shares is $417479.1 (2025), against an average of $1.1 million.
- The widest annual swing landed in 2024, when Treasury Shares tumbled 99.96%; it then jumped 37384.91% in 2025.
- A 3-year view of Treasury Shares shows it stood at $3.0 million in 2023, then sank by 99.96% to $1113.7 in 2024, then surged by 37384.91% to $417479.1 in 2025.
- The last three Treasury Shares figures came in at $417479.1 (Q4 2025), $1113.7 (Q4 2024), and $3.0 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 700,000.00 |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 34.70 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Ascentage Pharma Group International | 1.11 Bn | 937.28 Mn | - | 417,479.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 417,479.09 |
| Dec 31, 2025 | 417,479.09 |
| Dec 31, 2024 | 1,113.73 |
| Dec 31, 2024 | 1,113.73 |
| Dec 31, 2023 | 2.97 Mn |
| Dec 31, 2023 | 2.97 Mn |